eCommons@AKU
Obstetrics and Gynaecology, East Africa

Medical College, East Africa

4-30-2020

The PRECISE (PREgnancy Care Integrating translational Science,
Everywhere) database: open-access data collection in maternal
and newborn health
Laura A. Magee
Amber Strang
Larry Li
Domena Tu
Warancha Tumtaweetikul

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/eastafrica_fhs_mc_obstet_gynaecol
Part of the Obstetrics and Gynecology Commons

Authors
Laura A. Magee, Amber Strang, Larry Li, Domena Tu, Warancha Tumtaweetikul, Rachel Craik, Marina
Daniele, Angela Koech, Umberto D’Alessandro, and Marleen Temmerman

Magee et al. Reproductive Health 2020, 17(Suppl 1):50
https://doi.org/10.1186/s12978-020-0873-8

DATA NOTE

Open Access

The PRECISE (PREgnancy Care Integrating
translational Science, Everywhere)
database: open-access data collection in
maternal and newborn health
Laura A. Magee1*, Amber Strang1, Larry Li2, Domena Tu2, Warancha Tumtaweetikul2, Rachel Craik1,
Marina Daniele1, Angela Koech Etyang3, Umberto D’Alessandro4, Ofordile Ogochukwu4, Anna Roca4,
Esperança Sevene5,6, Paulo Chin6, Corssino Tchavana6, Marleen Temmerman3, Peter von Dadelszen1 and The
PRECISE Network

Abstract
In less-resourced settings, adverse pregnancy outcome rates are unacceptably high. To effect improvement, we
need accurate epidemiological data about rates of death and morbidity, as well as social determinants of health
and processes of care, and from each country (or region) to contextualise strategies. The PRECISE database is a
unique core infrastructure of a generic, unified data collection platform. It is built on previous work in data
harmonisation, outcome and data field standardisation, open-access software (District Health Information System 2
and the Baobab Laboratory Information Management System), and clinical research networks. The database
contains globally-recommended indicators included in Health Management Information System recording and
reporting forms. It comprises key outcomes (maternal and perinatal death), life-saving interventions (Human
Immunodeficiency Virus testing, blood pressure measurement, iron therapy, uterotonic use after delivery,
postpartum maternal assessment within 48 h of birth, and newborn resuscitation, immediate skin-to-skin contact,
and immediate drying), and an additional 17 core administrative variables for the mother and babies. In addition,
the database has a suite of additional modules for ‘deep phenotyping’ based on established tools. These include
social determinants of health (including socioeconomic status, nutrition and the environment), maternal comorbidities, mental health, violence against women and health systems. The database has the potential to enable
future high-quality epidemiological research integrated with clinical care and discovery bioscience.
Keywords: Open-source, Pregnancy, DHIS2, Placental disorders, eRegistry

Background
In less-resourced settings and particularly in subSaharan Africa, adverse pregnancy outcome rates are unacceptably high. This is reflected in global estimates of
maternal mortality of 216/100,000 live births (2016 estimates), stillbirths of 18.4/1000 live births (2015 estimates), and neonatal mortality of 18.0/1000 live births
(2017 estimates) [1–3]. While estimates of near-miss
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morbidity for mothers and newborns are thought to be
eight-fold higher [4, 5], there is no widespread routine
collection of relevant outcome data as there is for mortality that allows for more accurate estimates globally, by
region, and over time. Also, there is little data on health
care quality and access to procedures that have the potential to improve these outcomes.
To effect improvements in maternal, newborn, and child
health (MNCH) outcomes, we need accurate epidemiological data about rates of death and morbidity, as well as
the social determinants of health and processes of care.
These data are needed from each country (and ideally
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region) to contextualise strategies. This is particularly important as countries are in different stages of the obstetric
transition, with different health care infrastructures and
priority needs [6]. Obtaining these data is currently hampered by numerous practical barriers, including a lack of
standardisation of the predictor and outcome variables
collected and their definitions [7]. There is keen interest
in open-source software platforms, [8] self-programming
and database revision.
The PRECISE (PREgnancy Care Integrating translational
Science, Everywhere) Network is funded to collect epidemiological data and biological samples from women
and babies in western (The Gambia), eastern (Kenya), and
southern (Mozambique) sub-Saharan African countries.
The aim is to understand, in the African setting, the predictors of placental disorders (hypertension, fetal growth
restriction, and stillbirth) and determinants of their prognosis. The project will ‘deep phenotype’ around 10,000
pregnant women (and their babies), approximately 1500
of whom we anticipate will experience a pregnancy complicated by one of the placental disorders of interest (as
above). (We will also collect data on around 1800 nonpregnant women of reproductive age as a control group.)
We have designed the PRECISE database with the following needs of the global research community in mind:
(i) the movement away from purpose-built project databases so as to contain costs (initial and maintenance) and
facilitate data-sharing [9]; (ii) the need for strategic support for large-scale, high-quality, epidemiological research;
(iii) the desire to capitalise on the ubiquitous use of mobile
technology for data collection in facility and in community; and (iv) the desire for open-access resources. We
have built on previous work in outcome standardisation
(by the International Consortium for Health Outcomes
Measurement, ICHOM); data harmonisation (by the Global Pregnancy Collaboration, CoLab); the Manhiça Health
and Demographics Surveillance System (HDSS), and an

Fig. 1 PRECISE holistic approach to pregnancy research
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open-source, web-based health management information
system (HMIS) platform (by the Norwegian Institute of
Public Health).
In this manuscript, we describe our data collection platform of core and supplementary modules, with the potential to be used for high-quality epidemiological research. It
is a single electronic repository of information (i.e. eRegistry) that can be shared by health system administrators,
clinicians, clinical investigators, and discovery scientists
through links with a laboratory information system.

Methods
Given the focus of the PRECISE Network on placental disorders, the starting point was the CoLab ‘s COLLECT
database, designed for global studies in pre-eclampsia
[10]. COLLECT’s minimal and comprehensive data sets
were reviewed for their appropriateness for data collection
in our study sites, in terms of fields, definitions, and comprehensiveness for the purposes of the deep-phenotyping
to be undertaken in PRECISE [11]. Also, we reviewed the
software platform and connectivity requirements as we
knew internet access to be intermittent.
In anticipation of the need for additional content and
to enhance future usability, globally-recommended indicators in health management information systems for
MNCH were identified and included, as component
parts of key definitions (such as gestational age and
blood pressure [BP] values), rather than reportable indicators that may require interpretation or judgement
(such as a diagnosis of gestational hypertension) [12].
Variables were supplemented by review of the existing
standardised data collection forms in each study site, for
antenatal care (ANC), delivery, and ward care (antenatal
or postnatal).
The content of supplementary modules was based on the
holistic data needs of PRECISE (Fig. 1). These included the
social determinants of health (e.g., socioeconomic status,
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air quality, geography, or nutrition); maternal pre-existing
and infectious co-morbidities; maternal mental health; and
elements of health systems’ strength (related to access, barriers, and quality of care). Standardised tools were identified whenever possible to address each of these data
collection needs, based on needs-driven literature review
(e.g., for maternal morbidity) and the experience of the
PRECISE Network investigators.
The collection of biological specimens is recorded on
an affiliated laboratory information management system
(LIMS) described elsewhere. (For details of Baobab
LIMS, please see Craik et al. Reprod Health 2019, in
press [13].)

Results
The PRECISE protocol specifies prospective data collection into the PRECISE database, as pregnant women are
enrolled at facilities for: (i) routine ANC (i.e., ≈10,000
unselected pregnancies); or (ii) care of a placental disorder that is the focus of PRECISE (i.e., pregnancy
hypertension, suspected fetal growth restriction [FGR],
or intrauterine fetal death/stillbirth) if not already enrolled in PRECISE at that facility (i.e., ≈1500 women).
(Additional control women of reproductive age will be
enrolled when they present for contraceptive counselling
or in the company of another person who is presenting
for ANC or other care (i.e., ≈1800 women of reproductive age); in the Gambia, women of reproductive age will
be recruited in the community.) [(For details of PRECISE
Protocol, please see von Dadelszen et al. Reprod Health
2019, in press [14].) A project-specific eligibility screening has been designed to guide the study staff through
the details of participant selection and data collection,
documenting all information that would normally be recorded on a paper screening log, and eliminating the
need for the study staff to carry paper guidance.
Depending on the site, not all staff have clinical training. However, all have been trained on the content and
structure of the database, housed on android tablets (as
described below). The sequence of data collection follows the flow of women through the clinic care system
as much as possible.
Data fields

In choosing the content of the PRECISE database, we
reviewed all variables in the COLLECT ‘minimal’ or core
data set and the ‘comprehensive’ version of the database.
We supplemented our review with other MNCH instruments for measurement of demographics, pre-pregnancy
health or obstetric history, processes of care, or outcomes.
The 923 variables in PRECISE were organised according
into the following modules: (i) general visit information,
including identifiers and geoinformatics variables of relevance; (ii) baseline demographics and social determinants
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of health; (iii) past medical and obstetric histories; (iv) nutrition, an additional social determinant of health; (v)
current pregnancy details, including addiction and maternal mental health; (vi) details of assessments of pregnancy
hypertension, FGR, and intrauterine fetal death (IUFD)/
stillbirth; (vii) labour and delivery outcomes; (viii) maternal and newborn outcomes; and (ix) postpartum health
and health care (Table 1). (Further details about the origins of each variable in each module are contained in
Additional file 1, Tables S2A to S2N.)
The modules have the flexibility to be be grouped according to the data collection processes for PRECISE:
screening, PRECISE visit 1, PRECISE visit 2, information
from other ANC visits, pregnancy outcomes (birth, maternal, and newborn), and details of presentation with
placental disease (as relevant) or with laboratory results
(as applicable at any visit), as shown in Table 2.
The 25 core components are focussed on intrapartum
and immediate postpartum care as the time when most
adverse outcomes cluster. The components would be appropriate for future use as screening data collection and
would impose the lowest burden on the health system.
These cover globally-recommended indicators in national HMIS recording and reporting forms, as per a review of data elements related to maternal and newborn
health that were captured at different levels of the health
system by HMIS tools from 14 USAID priority countries
[12]. These core components consist of: (i) key mortality
outcomes, of maternal death, stillbirth, and neonatal
death (early and late); and (ii) life-saving interventions,
of Human Immunodeficiency Virus (HIV) testing, BP
measurement, iron therapy, uterotonic use after delivery,
postpartum maternal assessment within 48 h of birth,
and newborn resuscitation, immediate skin-to-skin contact, and immediate drying. Additional variables
complete the 17 core administrative variables for the
mother and baby. For the mother, these are: maternal
age, parity, weight, substance use, need for intensive care
as reflected by maternal near-miss morbidity, transfusion
of blood products, and maternal length of stay. For the
baby (ies), the core administrative variables are: spontaneous or iatrogenic preterm birth, sex, birthweight, birth
injury, and obvious major birth defects and broad type),
as well as location and mode of delivery [44]. These outcomes were developed by the ICHOM. To date, we have
not included patient-reported health status, satisfaction
with care, health care responsiveness, and birth experience, all of which would require specific data collection
tools and be hampered by low health literacy at our
study sites.
Given the deep-phenotyping mandate of PRECISE,
these core components were supplemented by additional
variables suitable for the immediate purpose of deepphenotyping in PRECISE, as well as for future use in
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Table 1 Content of modules
Modules

Description and tools

General visit information)

Identifiers for future contacta, including Health Demographic Surveillance System (HDSS) numbers, as
relevant
Geo-informatic variables of relevance, including from where the woman travelled to seek care, and how that
travel was achieved (as performed in the Community-Level Interventions in Pre-eclampsia [CLIP] Mozambique
Trial) [15, 16]

Baseline information & social
determinants of health

Maternal demographics and pre-existing morbidities (Demographic Health Survey 7 [17], COLLECT database
[11], and CLIP trials [18], informed by regionally-appropriate tribal categories in The Gambia, Kenya, and
Mozambique
Grameen Poverty Probability Index for Senegal (as a surrogate for The Gambia for which there is none),
Kenya, and Mozambique [19]
UN International Fund for Agricultural Development Multidimensional Poverty Assessment Tool, MPAT [20]
Education and occupation (as in the CLIP trials [18])
Social supports and transport (as in the CLIP trials [18])
Joint Monitoring Programme on Water Supply and Sanitation (JMP), WHO and UNICEF Multiple Indicator
Cluster Surveys (MICS)- Household Questionnaire 2017 [21]

Past medical and obstetric histories

COLLECT [11]
CLIP trials [18]
Demographic Health Survey 7 [17]

Nutrition

Dietary Diversity Score from the Healthy Life Trajectories Initiative (HeLTI) [22]

Current pregnancy details

COLLECT [11]
CLIP trials [18]
WHO recommendations on antenatal care for a positive pregnancy experience, 2016 [23]
Maternal Death Notification Form – South Africa 2014 [24]
Maternal mental health (WHO Maternal Woice Tool – antenatal care [25])

Details of placental disorders

COLLECT [11]
CLIP trials [18]
fullPIERS [26] and miniPIERS [27, 28] predictive models of adverse maternal and perinatal outcome in preeclampsia
Details of stillbirth in INDEPTH standardised verbal autopsy tool [29]

Labour and delivery

COLLECT [11]
CLIP trials [18]
Adverse maternal outcome by Delphi consensus (fullPIERS [26] and iHOPE [30])
World Health Organization. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience.
Geneva, Switzerland: World Health Organization, 2016 [23]
Preterm birth phenotype [31]
Intergrowth-21 standards for weight at birth [32]
Averting Maternal Death and Disability (AMDD) Needs Assessment Toolkit: Modules 9 (Chart review for
women with obstetric complications) and 10 (Chart review of newborn mortality) [33]
ICD-MM [International Classification of Disease-Maternal Mortality (ICD-MM [34])
Maternal Death Notification Form – South Africa 2014 [24], Kenya 2017 [35]
WHO 2011 Maternal Near-Miss Morbidity Approach [4] informed by an African Delphi Consensus process [36]
WHO verbal autopsy tool for stillbirths [37], INDEPTH Standardized Verbal Autopsy questionnaire [29]
International Classification of Disease-Perinatal Mortality (ICD-PM [38]
Ministry of Health Perinatal Death Review Form – Kenya (2017)
WHO Making Every Baby Count initiative [39]

Maternal and newborn outcomes

Postpartum health

a

Post-traumatic Stress Disorder Checklist-Civilian Version, PCL-C [40]
WHO Maternal Woice tool – postnatal care [41] (for mental health, violence against women and other
maternal morbidity)
WHODAS tool 2.0 [42] (health functioning)
EN-SMILING tool [43] (early childhood development and infant nutrition)
DHS-7 (also infant nutrition) [17]

To be stripped by encryption when data are transmitted to the central servers at UBC

different locations (depending on needs and interest) or
at different times (to monitor trends, depending on regional/national/global needs). The variables were defined
according to various context-specific sources. COLLECT
definitions were used whenever possible, for the 60/923
variables shared with the COLLECT minimal dataset;

however, definitions were not always deemed feasible to
use from COLLECT given response options that were
not appropriate for our study settings (e.g., ethnicity categories that could not be mapped to context-specific options), unavailability of the intervention (e.g., invasive
prenatal diagnosis), and/or the absence of robust clinical
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Table 2 Presentation of data collection in PRECISE database
Icons in PRECISE (DHIS2)a

a

Timing of data collection

Applicable modules

Screening (eligi-bility & data collection (each visit)

(Study or setting-specific)

PRECISE visit 1

• General visit information
• Baseline demographics and social determinants of health
• Past medical and obstetric histories
• Nutrition
• Current pregnancy details

PRECISE visit 2

• General visit information
• Current pregnancy details

Other ANC visit (each)

• Current pregnancy details (basic)

Birth (labour and delivery, maternal and baby outcomes)

• Labour and delivery
• Maternal and newborn outcomes

Presentation with placental disease (any visit)

• Details of placental disorders

Laboratory results (any visit)

(Relevant to all modules at any visit)

The REDCap interface has a ‘select event’ list

records (e.g., family history of pre-eclampsia). A particular concern was the use in COLLECT of some overarching stem questions (such as occurrence of “maternal
morbidity”) that relied on high health literacy of the data
collectors who only if answering ‘yes’, would see questions about specific morbidities; health literacy is variable among women, care-providers, and data collectors
in our study settings. In contrast, we focussed on clinical
data that care-providers routinely document, not “reportable indicators”; for example, care-providers record
the BP measurement and use the system-generated date
and gestational age to autogenerate a diagnosis of gestational hypertension at 20 weeks. This general principle
was respected throughout, such as for maternal and neonatal near-miss morbidity [4, 5, 45].
To ensure high-quality of data, programme rules were
added to implement skip-logics and cross-validation

rules for checking inconsistencies in real time. Each
module has a ‘See details’ option, the programming of
which is customised to provide the key details of relevance to the user.
The woman’s study identifier is used to link her
epidemiological data with biorepository samples
tracked in Baobab LIMS, the LIMS chosen for the
project given it is open-source and its development
to facilitate harmonisation of biobanks across Africa,
our geographical focus. In this way, a participant’s
personal health information is not attached to any
specimen in the Baobab LIMS database. Executable,
customised programmes have been created to be run
periodically by the data manager to transmit biobanking core data into the database. (For details of
Baobab LIMS, please see Craik et al. Reprod Health
2019, in press [13].)
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Software

The PRECISE database is based on the District Health Information System 2 (DHIS2) software and its application,
Tracker. First, DHIS2 is widely used (by 67 low and
middle-income countries) and, importantly, has been implemented in the Palestinian Territories as the national
eRegistry for maternal and child health [46]. The Tracker
application provides capacity for individual-level data
entry. Second, Tracker is flexible, easily set-up, opensource, and accessed using a variety of tools, including android tablets and smartphones, to maximise flexibility of
data collection at service delivery points [47]. If internet
connectivity is lost, work can continue offline to facilitate
efficient and effective data management. There is a ‘share’
function that generates a QR code (i.e., a machinereadable optical label that contains the relevant information about a PRECISE participant) that, if scanned by another device, will transfer the woman’s information to
another PRECISE tablet, allowing for data collection without interruption. Finally, the mandate of PRECISE includes capacity-building in Africa, and DHIS2 Tracker has
the greatest potential to form the basis for an eRegistry.
DHIS2 is packaged as a standard Java Web Archive file
and runs on any Servlet container with Java Runtime Environment version 8 or higher installed, including the
need for a web server and a database server with sufficient
memory and storage space. As the preferred software environment for production server, Ubuntu 16.04 LTS operating system, PostgreSQL database and Tomcat Servlet
are recommended. Training materials have been written
so that those entering data have requisite skills to ensure
accuracy [47].
Other software was considered. We found the structure
of the COLLECT database challenging for the purposes of
PRECISE. First, we had available to us either all of the field
labels (variables and their characteristics) in the minimal
dataset (i.e., ≈500) or all in the comprehensive dataset (i.e.,
≈5000), but neither approach was realistic due to challenges with individual variables, as outlined above. Second,
the MedSciNet software required continuous connectivity
for data entry, but this is not available at our sites. We
considered Open Data Kit, a mobile data management application that has been widely deployed in more than 130
countries [48]; however, the application (app) cannot handle frequent changes to the data model and we sought a
resilient system for future use [49]. We considered Open
Medical Record System, created as an open-source health
software for low-resource settings [50]; while widely-used
for HIV care, this is not the case for antenatal and postnatal care of mothers and babies. Finally, we considered Research Electronic Capture (REDCap) software, as it is
widely used and open-access; however, REDCap does not
have a personal dashboard, may not support well repeatable instruments and events, and the website has only a
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report tool with filters, rather than analytical tools needed
for future functionality.
We did experience difficulties with the very large
volume of questions to be asked in PRECISE which
caused the DHIS2 Android Capture app to perform
very slowly; a work-around was created to decrease
the volume of data collection associated with any one
‘icon’ (as in Table 2), and this dramatically improved
speed. However, in testing, the software was still not
syncing 100% of all data entered, a problem experienced by other software users. In addition, the personal dashboard of a participant across multiple
programmes (or tiles) was not always updated automatically if it was not opened in a programme. Given
our need to start PRECISE data collection, we opted
to begin on REDCap software that is compatible with
the technical specifications of DHIS2 with which it
has a similar look and feel (Fig. 2). Further testing
will determine whether we revert to direct use of
DHIS2, or remain with the REDCap interface.
In the PRECISE database, all participants are given a
unique study identifier. Personal information is collected
and held on a local database kept in a locked environment, with direct access restricted to authorised individuals who are responsible for monitoring and backing up
the system. All other access to the database is controlled
by logical security with access control and across a
standard secure Hyper Text Transfer Protocol Secure
network protected by a firewall and system controls with
authentication, role-based authorisation, and audit trails.
Strong password policies include password length and
complexity restrictions. All database back-ups are
encrypted and local Information Technology security
policies and procedures followed.
Data collection tablets are password-protected and
back-ups are encrypted. Each user logs into the app
with a strong username and password, ensuring the
study participant’s confidentiality even with loss of
tablets. Data are synchronised with local servers via
secure connections, preferably daily. To ensure confidentiality, only authorised staff have access to personal information to facilitate data collection and
cleaning. Loss or damage of a tablet that results in
loss of data would be reported immediately. Information would be erased before any damaged tablets
were recycled. Only password-protected computers
running an antivirus program are used to download
and process personal information for data linkage
and cleaning.
All data are stored locally on high capacity servers
stored in locked rooms. Extra measures for security include auxiliary power and continuous system monitoring. A tape back-up system is used for the database (and
website).
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Fig. 2 Interfaces for (a) DHIS2 Tracker and (b) REDCap

A copy of all de-identified qualitative, clinical,
geo-informatic, and laboratory data are stored on a
remote server located at the British Columbia
Children’s Hospital Research Institute with daily
backup and management by the PRE-EMPT team
(PREgnancy Evidence, Monitoring, Partnerships and
Treatment) at the University of British Columbia
(UBC). Data are stored on a secure database on a
high-speed network with access control, and servers
are stored in a secure locked server room with restricted access to authorised system administrators.
When data are sent for merging with master
databases, research staff will keep a copy on their
restricted network drive. The final dataset along
with hard copies of results will be kept for at least
10 years.

For PRECISE, in each country, the database system is
hosted and managed by local IT system administrators
who are responsible for network security and access
control, system updates, database back-up and recovery,
and the in-country computer updates, in compliance
with local IT network, system, and security policies. The
data manager has set up and configured the database,
tested the system functionalities, updated ‘meta-data’
(that help users find relevant information within the
database), and installed/configured mobile apps on the
tablets. The data manager is responsible for importing
and exporting data, monitoring data updates, audit trails
and reports, and resolving data queries within the study
team.
It is the duty of sites to ensure data collected are
complete and accurate and to run validation rules. Data
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are queried periodically by the local data manager to
check for timely data collection and synchronisation,
missing information, and discrepancies. Only deidentified data will be transmitted to the UBC central
database, preferably on a weekly basis, through a secure
connection with 256-bit Secure Sockets Layer encryption. At UBC, data queries are run and a query report
with feedback provided to each site’s local data managers. The data query report focusses on missing values
without reasonable comments, out-of-range values, and
data inconsistencies that violate validation rules. The report is designed to be reviewed and the queries resolved
with the local team. Built-in audit trails provide historical records of data-update activities.
Compliance with General Data Protection Regulation (GDPR) is reliant on both the database and the
operational policies, procedures and processes of the
local study teams, to ensure that the necessary steps
are taken to: obtain appropriate informed consent for
data management (including collection, retention,
sharing, disposal, and dispute); staff training; designation of a Data Protection Officer; tablet protection;
server/platform protection; and detection and reporting of breaches. In addition, consent to participate in
any project involving the database must protect participants’ eight individual rights under GDPR to: be
informed, access, rectification, withdrawal of consent,
erasure, restriction of processing (of data), data portability, and objection.
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answer these questions in the ANC setting, as well as
the lack of well-established care pathways for women
identified as having issues or being at high risk; antenatal and postnatal modules containing these questions are currently offline while we undertake care
pathway mapping to prepare for the inclusion of
these questions during the course of the project.

Discussion
The PRECISE database as designed is a unique infrastructure of a generic, unified data collection platform of core and supplementary variables that cover
globally-recommended indicators included in HMIS
recording and reporting forms, comprised of: key
outcomes, life-saving interventions, and an additional
17 core administrative variables for the mother and
babies. In addition, the database has a suite of additional variables designed for ‘deep phenotyping’ related to the placental disorders of hypertension, FGR,
and stillbirth, but which are widely applicable for
studying pregnancy-related conditions: social determinants of health, maternal co-morbidities, nutrition,
mental health and domestic violence. The data elements and definitions have been standardised to
comply with existing data dictionaries and/or tools,
from international clinical, research, and policy organisations, including the WHO, as well as efforts for
international outcomes standardisation. The software
platform is DHIS2, which is open-access and supported by free programming training by the University of Oslo as a WHO Collaborating Centre.

Challenges

Our challenge related to our planned software platform,
DHIS2, has been discussed above. Additional challenges
relate to implementation of database content.
First, the World Health Organization (WHO) ANC
guidelines recommend that, “Health-care providers
should ask all pregnant women about their tobacco
use (past and present) and exposure to second-hand
smoke as early as possible in the pregnancy and at
every antenatal care visit”, and, “Health-care providers should ask all pregnant women about their
use of alcohol and other substances (past and
present) as early as possible in the pregnancy and at
every antenatal care visit” [23]. Our in-country teams
customised these questions to deal with cultural
sensitivities.
Second, given the critical importance of mental
health in pregnant and postpartum women, we had
planned to integrate the WHO ‘WOICE’ tool for
measurement of maternal morbidity, to which we
added a scale of post-traumatic stress disorder [25,
41]. However, in-country teams were not comfortable
due to the lack of both privacy in which to ask and

Strengths and limitations

Data collection at the point of clinical care is enabled by
the modular structure of the PRECISE database. This approach to an electronic health record is both longitudinal and truly prospective, so collection of relevant
clinical data will precede outcomes, which means that
they cannot be biased by those outcomes. Specifically,
predictors will be collected prior to occurrence of a placental disorder, and a placental disorder prior to the occurrence of maternal and perinatal mortality and
morbidity. This is critical to understanding the epidemiology and true denominator and numerator of adverse
outcomes, such as stillbirths, a major contributor to lives
lost in Reproductive MNCH (RMNCH).
DHIS2, on which Tracker is programmed, is sustainable. The core software development team is
hosted as a “global public good” at the University of
Oslo, a world leader in HMIS strengthening in lessdeveloped countries; DHIS2 has been implemented,
at least regionally, in 87 countries and Indian states,
with 53 operating at national scale. The University of
Oslo also contributes by offering in-country capacity
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building and implementation support and research,
and as a WHO Collaborating Centre for Innovation
and Implementation Research.
Limitations of the PRECISE database include how
the questions must be structured; any responses for
which ‘mark all that apply’ is appropriate must be
phrased as different questions. Fields cannot currently
be auto-filled from earlier data entries on the Android app; for example, if a woman has indicated that
she is HIV positive on a previous form, Tracker will
not automatically fill in later fields recording her HIV
status. Also, images from supporting documentation
(such as visual aids to describe sanitation facilities)
cannot currently be uploaded and stored on the
DHIS2 Android app. There is no offline data capture
app that is supported on an Apple operating system
device; however, the platform can still be accessible
via internet through Safari or Chrome browsers if installed on an Apple device.
The literature

The WHO promotes client registry-based health information systems as one of the most promising avenues to support quality universal health coverage in
RMNCH. While most less-developed countries have
national eHealth plans, a lack of harmonisation and
capacity-building risks squandering opportunities for
research and collaboration.
A standardised approach to RMNCH data field
collection is critical. Measurement strategies must
be consistent across communities and countries,
and over time, in order to benchmark and address
underlying differences, improve outcomes and reduce disparity. The Bill & Melinda Gates Foundation (BMGF)-funded Healthy Birth, Growth, and
Development – knowledge integration initiative is assembling ‘big data’ and novel analytic data rallies
(focussed analytic efforts) from more than 170
BMGF-funded projects, involving ≈12 million subjects from 34 countries, to inform key questions in
child health and development [51]; the investigators
will drill down through masses of data looking for
patterns, statistical anomalies, and other newly discovered facts to inform new hypotheses in clinical
research, and fashion updated clinical guidelines
and protocols [52]. However, the initiative faces the
challenge of different data fields, with different definitions, and different platforms – the same challenge faced by individual patient data meta-analyses
in pregnancy. For example, in its synthesis of international angiogenic biomarker data (22 pregnancy
cohorts, 16,462 pregnancies), the BMGF-funded
CoLab estimates that more than 300 h were required to map data fields and definitions from one
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cohort to another, in order to find common ground
on which to base the data synthesis [53].
Electronic health (eHealth) technology is the most
frequently cited opportunity for maternal health
among international researchers [54]. eHealth has
been described as the … use of information and
communications technologies in support of health
and health-related fields, including health care services, health surveillance, health literature, and health
education, knowledge, and research [52]. At a global
level, health data may: (i) not be captured at all; or
if collected, (ii) captured but multiple times in multiple ways, or (iii) captured but in a way that cannot
be shared due to interoperability issues or a lack of
standardised definitions. This is not surprising given
that approximately half of all referral facilities rely
on paper data management [30]. The implications
are illustrated by estimates of the maternal mortality
ratio (per 100,000 live births) in Lesotho that vary by
over 10-fold depending on the data source– 100/100,
000 based on their confidential enquiry into maternal
deaths, 500/100,000 according to entry of aggregate
data from a paper birth registry into DHIS2, and
1057/100,000 as reported by the Demographic Health
(household) Survey [Personal communication, B Pattinson 2018 Oct 4].
Making data valuable to the collector is the key to
obtaining quality data, and lack of data use where it
is collected has been cited as the weakest part of
the HMIS in many countries [55]. In contrast, collecting data at point-of-care, in an electronic record
with decision- and work-flow support, is designed
with care providers in mind as both users and
beneficiaries.
While many countries are implementing health registries in various forms, very few can act as an integrating
backbone for health information and bioscience, clinical, and epidemiological research [56]. This is unrelated to the fact that the majority are in transition from
paper-based data to digital data collection systems, but
rather that even when fully implemented, the current
bespoke ‘top-down’ solutions may not capture locallyrelevant determinants of outcomes or be inter-operable
between countries. Additionally, local/regional ‘bottomup’ efforts or bespoke databases for specific research
projects are not standardised and thus, unable to monitor national trends [52].
eRegistries are systems using information and communication technologies for the systematic longitudinal collection, storage, retrieval, analysis, and
dissemination of uniform information on the health
determinants and outcomes of individual persons, to
serve diverse stakeholders, including those providing
health care services or health surveillance, and those
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conducting research [56]. eRegistries are feasible and
have been successfully implemented in MNCH [56].
Most undertake duplicate data collection on paper
with transfer to an electronic database (e.g., Maternal
Newborn Health Registry of the National Institutes
of Health and BMGF-funded Global Health Network). However, some countries (e.g., Kenya) have
published research based on primary data entry in
fully electronic registries at national or regional
levels, and individual records have also been linked
with laboratory tests and biorepositories [56, 57], and
a fully-functional eRegistry programmed on DHIS2
with decision support is currently being evaluated in
the Palestinian Territories [46].
The strengths and operational challenges of DHIS2
have been recently reviewed systematically, in 20
studies from 11 countries [47]. The most important
strengths were the technical features of the software
(e.g., open-source); proper management of data (e.g.,
data entry at point of service provision); and application flexibility (e.g., ability to customise to meet local
needs and sustainability of software); all are being
leveraged in PRECISE. The most important operational challenges were management/leadership (e.g.,
proper planning for establishment) and training (e.g.,
of staff), sufficient workforce, appropriate communication infrastructure (e.g., internet), and the political,
cultural, social and structural infrastructure (including linguistic challenges). All of these are being addressed in PRECISE, by staff hiring, training sessions
and materials, close supervision, provision of enhanced internet capabilities (although not continuous), and a strongly supportive leadership, including
local governmental officials.
While follow-up in PRECISE is currently to 6 weeks
postpartum, it is critical to develop mechanisms to facilitate long-term follow-up. Conducting PRECISE in collaboration with the Manhiça Health Research Centre
affords us the opportunity to link our database with the
routine morbidity surveillance conducted for all children
under 15 years of age who attend for inpatient or outpatient care in the area covered by their HDSS [58].
Finally, there is a need to understand which component(s) of packages of care are key elements of successful interventions. For example, the WHO eightcontact ANC model includes health promotion and
nutritional interventions, and prevention and early detection of selected pregnancy-related conditions and
concurrent diseases, including malaria, HIV, and tuberculosis. There are currently significant knowledge
gaps that impede optimisation of care, given: the
complexity of factors to consider; the need for countries to adapt recommendations based on their country context and populations’ needs; and the inability
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of rigorous study methods (such as randomised trials)
to evaluate each individual component of such packages, particularly in various settings. However, the
volume and quality of data collected in an eRegistry
can facilitate an understanding of the effects of multiple mediators, while accounting for unobserved confounders, using a counter-factual approach with
multiple simulations from observed data, and bootstrapping for confidence intervals. Taking the eightvisit WHO ANC model, one could ask if it is necessary to measure proteinuria at every ANC visit? Or,
what is the value of screening for hypertension at 32
weeks’ gestation, in relation to other potential mediators of any observed effect (Fig. 2)?

Conclusions
We seek to build on PRECISE (in Africa) and the eRegistry concept by developing a generic, unified data collection platform that links clinical research and clinical
care, thereby creating both a ‘learning health system’ for
care-providers, and a monitoring, learning and evaluation system for academics and health administrators.
Research could take the form of large-scale epidemiological work, clinical trials, implementation science, or
discovery science by linking clinical data with stored biological samples logged in a LIMS system. Distributed
analytical software packages (such as DataSHIELD) can
now enable real-time, in-country analyses and research
collaborations. In addition, there is potential to integrate
decision support, facilitate remote access and analyses,
and replace manual aggregation of data from multiple
sources with electronically-generated reports for submission to central authorities, thus providing a mechanism
for governments and other international agencies to
monitor trends and identify priorities for more detailed
data collection.
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